LOCALIZATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCTION IN INFLAMED APPENDIX BY INSITU MESSENGER-RNA HYBRIDIZATION

被引:32
作者
WHAWELL, SA
WANG, YM
FLEMING, KA
THOMPSON, EM
THOMPSON, JN
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT SURG,LONDON W12 0HS,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND
[3] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
基金
英国惠康基金;
关键词
INSITU HYBRIDIZATION; PLASMINOGEN ACTIVATOR INHIBITOR-1; PERITONEUM; ADHESIONS; MESOTHELIUM;
D O I
10.1002/path.1711690111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The peritoneum has been shown to possess fibrinolytic activity which is thought to play a role in the prevention of intra-abdominal adhesion formation. Recently inflamed peritoneal tissue has been shown to have reduced fibrinolytic activity secondary to increased levels of plasminogen activator inhibitor-I (PAI-1). The aim of this study was to localize the production of PAI-I in appendix tissue using in situ mRNA hybridization. Sections of normal and inflamed appendix were hybridized with a digoxigenin-labelled cDNA probe. PAI-1 production was localized to both mesothelium and serosal blood vessel endothelium in all inflamed appendix samples. Cell identities were confirmed using immunohistochemistry directed against mesothelial and endothlial cell markers. Staining was not seen on sections of normal appendix or on negative control slides of inflamed appendix (hybridization with plasmid DNA, PAI-1 probe following ribonuclease digestion). The identification of the cells expressing the PAI-1 gene in peritoneum increases our understanding of the pathophysiological changes in fibrinolytic activity which occur in inflammation and may lead to adhesion formation.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 29 条
  • [1] INDIRECT IMMUNOENZYME TECHNIQUES FOR INTRACELLULAR DETECTION OF ANTIGENS
    AVRAMEAS, S
    [J]. IMMUNOCHEMISTRY, 1969, 6 (06): : 825 - &
  • [2] UNIFYING PATHOGENETIC MECHANISM IN ETIOLOGY OF INTRAPERITONEAL ADHESIONS
    BUCKMAN, RF
    WOODS, M
    SARGENT, L
    GERVIN, AS
    [J]. JOURNAL OF SURGICAL RESEARCH, 1976, 20 (01) : 1 - 5
  • [3] CARLIN G, 1983, THROMB HAEMOSTASIS, V50, P145
  • [4] CHAPMAN HA, 1990, J IMMUNOL, V145, P3398
  • [5] GENERATION IN PLASMA OF A FAST-ACTING INHIBITOR OF PLASMINOGEN-ACTIVATOR IN RESPONSE TO ENDOTOXIN STIMULATION
    COLUCCI, M
    PARAMO, JA
    COLLEN, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) : 818 - 824
  • [6] INTERLEUKIN-1 AND LIPOPOLYSACCHARIDE INDUCE AN INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR INVIVO AND IN CULTURED ENDOTHELIAL-CELLS
    EMEIS, JJ
    KOOISTRA, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) : 1260 - 1266
  • [7] OPTIMIZATION OF NONISOTOPIC INSITU HYBRIDIZATION ON FORMALIN-FIXED, PARAFFIN-EMBEDDED MATERIAL USING DIGOXIGENIN-LABELED PROBES AND TRANSGENIC TISSUES
    FLEMING, KA
    EVANS, M
    RYLEY, KC
    FRANKLIN, D
    LOVELLBADGE, RH
    MOREY, AL
    [J]. JOURNAL OF PATHOLOGY, 1992, 167 (01) : 9 - 17
  • [8] SEROSAL HYPOFIBRINOLYSIS - CAUSE OF POSTOPERATIVE ADHESIONS
    GERVIN, AS
    PUCKETT, CL
    SILVER, D
    [J]. AMERICAN JOURNAL OF SURGERY, 1973, 125 (01) : 80 - 88
  • [9] HAU T, 1989, SURG IMMUN, V2, P1
  • [10] HUMAN-ENDOTHELIAL CELLS CONTAIN ONE TYPE OF PLASMINOGEN-ACTIVATOR
    KRISTENSEN, P
    LARSSON, LI
    NIELSEN, LS
    GRONDAHLHANSEN, J
    ANDREASEN, PA
    DANO, K
    [J]. FEBS LETTERS, 1984, 168 (01) : 33 - 37